A Microalgae‐Probiotic‐Nanozyme Robot for Alleviating Intestinal Inflammation and Microbiota Dysbiosis

Inflammatory bowel disease is chronic gastrointestinal disorder characterized by persistent intestinal inflammation, which can lead to severe complications such as impaired intestinal barrier function and dysbiosis. Conventional therapies have challenges such as oxidative stress and insufficient intestinal colonization that hinder the treatment efficacy. Therapeutic strategies based on micro-nano robotic delivery are promising to address the limitations of current treatments by enabling precise targeting, enhancing bioavailability, and improving therapeutic outcomes. Herein, an orally administered micro-nano robot is developed utilizing Spirulina platensis as a carrier for nanozyme-armed probiotic Lactobacillus plantarum (SP@LP@AuCe) to enhance the efficacy of oral probiotics and nanomedicine in treating intestinal diseases. SP@LP@AuCe exhibits strong fluorescence imaging capability due to its chlorophyll-rich content, allowing for non-invasive and real-time monitoring following oral administration. The helical structure of Spirulina platensis facilitates entrapment in intestinal villi that enhances intestinal retention. Importantly, SP@LP@AuCe scavenges reactive oxygen species and modulates inflammatory responses, thereby alleviating intestinal inflammation, improving bacterial viability, and restoring the balance of intestinal microbiota. This strategy integrates microalgae, probiotics, and nanozymes within a micro-nano robotic framework, presenting a promising approach to enhancing drug bioavailability and exerting potent anti-inflammatory effects in the treatment of intestinal diseases.